Published October 22, 2013 | Version v1
Journal article Open

Energy metabolism and fertility: a balance preserved for female health.

  • 1. Center of Excellence on Neurodegenerative Diseases, University of Milan, 20133, Milan, Italy and Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133, Milan, Italy
  • 2. Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133, Milan, Italy and Italian Institute of Technology, 16163, Genova, Italy
  • 3. Center of Excellence on Neurodegenerative Diseases, University of Milan, 20133, Milan, Italy

Description

In female animals, energy metabolism and fertility are tightly connected, and reciprocally regulated. However, the relative contributions of metabolic and reproductive pathways have changed over the course of evolution. In oviparous animals, metabolic factors take precedence over fertility, enabling egg production to be inhibited in a nutritionally poor environment. By contrast, in placental mammals, the opposite occurs: the need to feed a developing embryo and neonate forces metabolic pathways to adapt to these reproductive needs. This physiological necessity explains why in female mammals alterations of gonadal activity, including age-dependent cessation of ovarian functions, are associated with a disruption of metabolic homeostasis and consequent inflammatory reactions that trigger the onset of metabolic, cardiovascular, skeletal and neural pathologies. This Review discusses how metabolic homeostasis and reproductive functions interact to optimize female fertility and explains the pathogenic mechanisms underlying the disordered energy metabolism associated with human ovarian dysfunction owing to menopause, polycystic ovary syndrome and Turner syndrome. Finally, this article highlights how hormone replacement therapy might aid the restoration of metabolic homeostasis in women with ovarian dysfunction.

Files

Della_Torre_NatRevEndocrinol_2014-P02-AAM.pdf

Files (6.1 MB)

Name Size Download all
md5:3ab60c690a063992e8ab043c1b245ef1
6.1 MB Preview Download

Additional details

Funding

INMIND – Imaging of Neuroinflammation in Neurodegenerative Diseases 278850
European Commission